All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
Introducing
Now you can personalise
your Lupus Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe Lupus Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lupus Hub cannot guarantee the accuracy of translated content. The Lupus Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lupus Hub is an independent medical education platform, supported through a grant from AstraZeneca. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which the pathophysiology includes immune dissonance, genetic predisposition, epigenetic dysregulation, and dysbiosis of microbiota. SLE is life-threatening, more prevalent in women, and characterized by organ damage and a relapsing remitting course. SLE has highly heterogeneous clinical manifestations, which overlap with many other rheumatoid diseases, hematopoietic malignancies, and infections, which can hamper diagnosis. SLE is most likely to affect the skin, joints/muscles, kidneys, and blood vessels.
Save to your areas of interest